MAPT and Alzheimer disease: While some regions we identified overlapped with common areas of β-amyloid and tau deposition (Braak and Braak, 1991; Braak et al., 2011), it is not possible to apply pathological models without longitudinal data, and on a mixed cohort of AD and MCI patients.